Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 89.43% is 44% above its 5-year average of 61.90%, near the high end of its 5-year range (43.90%–89.43%).
10.31% above its 12-month average of 81.07%.
Annual fiscal-year return on equity; no daily interpolation.
RETURN ON EQUITY (ROE)
89.43%
RETURN ON EQUITY (ROE) AVG TTM
81.07%
RETURN ON EQUITY (ROE) AVG 3Y
67.39%
RETURN ON EQUITY (ROE) AVG 5Y
61.90%
RETURN ON EQUITY (ROE) AVG 10Y
63.76%
RETURN ON EQUITY (ROE) AVG 15Y
43.40%
RETURN ON EQUITY (ROE) AVG 20Y
36.89%
CURRENT VS TTM AVG
+10.31%
CURRENT VS 3Y AVG
+32.71%
CURRENT VS 5Y AVG
+44.48%
CURRENT VS 10Y AVG
+40.26%
CURRENT VS 15Y AVG
+106.05%
CURRENT VS 20Y AVG
+142.43%
SECTOR MEDIAN · HEALTHCARE
13.38%
median of 76 covered companies
CURRENT VS SECTOR MEDIAN
+568.39%
vs the sector median at left
NRC Health
Market Cap
$483.86M
Return on Equity (ROE)
89.43%
TTM Avg
81.07%
3Y Avg
67.39%
5Y Avg
61.90%
Market Cap
$410.41M
Return on Equity (ROE)
-28.18%
TTM Avg
-52.50%
3Y Avg
-47.15%
5Y Avg
-47.15%
Market Cap
$1.23B
Return on Equity (ROE)
-13.54%
TTM Avg
-40.81%
3Y Avg
-170.75%
5Y Avg
-114.78%
Market Cap
$2.34B
Return on Equity (ROE)
-40.41%
TTM Avg
-45.75%
3Y Avg
-30.11%
5Y Avg
-18.95%
Market Cap
$3.09B
Return on Equity (ROE)
29.28%
TTM Avg
27.86%
3Y Avg
4.54%
5Y Avg
-12.45%
Market Cap
$6.82B
Return on Equity (ROE)
-43.83%
TTM Avg
25.09%
3Y Avg
5.57%
5Y Avg
0.40%
Market Cap
$7.21B
Return on Equity (ROE)
26.84%
TTM Avg
-21.41%
3Y Avg
-36.14%
5Y Avg
-25.75%
Market Cap
$9.60B
Return on Equity (ROE)
3.10%
TTM Avg
-8.94%
3Y Avg
-15.72%
5Y Avg
1.14%
Market Cap
$9.79B
Return on Equity (ROE)
-57.18%
TTM Avg
-651.33%
3Y Avg
-315.37%
5Y Avg
-198.08%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NRC Health (NRC) | $483.86M | 89.43% | 81.07% | 67.39% | 61.90% |
| Shoulder Innovations, Inc. (SI)vs › | $410.41M | -28.18% | -52.50% | -47.15% | -47.15% |
| Teladoc Health, Inc. (TDOC)vs › | $1.23B | -13.54% | -40.81% | -170.75% | -114.78% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.34B | -40.41% | -45.75% | -30.11% | -18.95% |
| TransMedics Group, Inc. (TMDX)vs › | $3.09B | 29.28% | 27.86% | 4.54% | -12.45% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.82B | -43.83% | 25.09% | 5.57% | 0.40% |
| Oscar Health, Inc. (OSCR)vs › | $7.21B | 26.84% | -21.41% | -36.14% | -25.75% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.60B | 3.10% | -8.94% | -15.72% | 1.14% |
| Tempus AI, Inc. (TEM)vs › | $9.79B | -57.18% | -651.33% | -315.37% | -198.08% |
| Insulet Corp. (PODD)vs › | $10.01B | 26.39% | 25.41% | 19.99% | 14.02% |
ROE
89.4%
ROA
4.3%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2025-12-31 | 82.92% |
| 2024-12-31 | 79.22% |
| 2023-12-31 | 63.26% |
| 2022-12-31 | 44.15% |
| 2021-12-31 | 43.90% |
| 2020-12-31 | 57.93% |
| 2019-12-31 | 98.52% |
| 2018-12-31 | 157.45% |
| 2017-12-31 | 25.48% |
| 2016-12-31 | 24.78% |
| 2015-12-31 | 23.73% |
| 2014-12-31 | 20.69% |
| 2013-12-31 | 21.58% |
| 2012-12-31 | 26.56% |
| 2011-12-31 | 20.82% |
| 2010-12-31 | 17.49% |
| 2009-12-31 | 19.22% |
| 2008-12-31 | 19.29% |
| 2007-12-31 | 16.17% |
| 2006-12-31 | 16.01% |
| 2005-12-31 | 16.06% |
| 2004-12-31 | 13.00% |
| 2003-12-31 | 13.52% |
| 2002-12-31 | 13.74% |
| 2001-12-31 | 7.15% |
| 2000-12-31 | 12.71% |
| 1999-12-31 | 8.06% |
| 1998-12-31 | 2.87% |
| 1997-12-31 | 17.68% |
| 1996-12-31 | 109.52% |
